Autologous Bone Marrow-derived Mononuclear Cells
13-006427
Phase 1 mab completed
Quick answer
Autologous Bone Marrow-derived Mononuclear Cells for Congenital Heart Disease is a Phase 1 program (mab) at Regen BioPharma Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regen BioPharma Inc
- Indication
- Congenital Heart Disease
- Phase
- Phase 1
- Modality
- mab
- Status
- completed